Dr. Ankur Bahl is a highly skilled cancer specialist who has more than 15+ years ofrich experience in this field. He is an alumni of Maulana Azad Medical CollegeDelhi from where he did his MBBS, followed by MD Medicine. He has done his DMMedical Oncology from the prestigious AIIMS New Delhi. He has also completeda course on Adverse Drug Reactions, Drug Interactions and Pharma covigilance at the University of Oxford UK. Dr. Bahl holds clinical expertise inImmunotherapy, targeted therapies in combination with Chemotherapy,Hormonal Therapy, Supportive and Palliative Care.    He is the lead author of largest real world Indian data on targeted therapy(Cetuxmab) in Head & Neck cancer, Acute Myeloid Leukaemia Treatment,Human Pappiloma Virus trends in Indian Population etc. He is also the leadfounder of various innovative oncology educational platforms and networks(International and national) Evidence based debates in oncology, Live Oncology Tumour boards, Master Classes andworkshops in oncology Dr Bahl has joined FMRI, Gurugram from Max Hospital, Saket where he was Director- Medical Oncology and HaematologyOncology, Previously he was associated with prestigious organisation like Rajiv Gandhi Cancer Institute and ResearchCentre and Maulana Azad Medical College.

Innumerable Publications in International and National Journal / Books of repute. Lead Author of largest real world Indian data on Targeted therapy (Cetuximab )in head and neck cancer, Acute Myeloid leukaemia treatment, Human Papilloma Virus trends in Indian Population etc. Lead founder of various innovative oncology educational platforms and networks (International and national) : Evidence based debates in oncology, Live oncology tumour boards , Master classes and workshops in oncology.Advisors to various Biopharmaceutical Research & Development Professional Guides to various international and national Medical oncology fellows and students. Lead various NGO’s for "No Tobbaco" workshop for teens in Delhi Schools